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Abstract: Pathogenic bacteria of the Burkholderia pseudo-
mallei group cause severe infectious diseases such as glanders
and melioidosis. Malleicyprols were identified as important
bacterial virulence factors, yet the biosynthetic origin of their
cyclopropanol warhead has remained enigmatic. By a combi-
nation of mutational analysis and metabolomics we found that
sulfonium acids, dimethylsulfoniumpropionate (DMSP) and
gonyol, known as osmolytes and as crucial components in the
global organosulfur cycle, are key intermediates en route to the
cyclopropanol unit. Functional genetics and in vitro analyses
uncover a specialized pathway to DMSP involving a rare
prokaryotic SET-domain methyltransferase for a cryptic meth-
ylation, and show that DMSP is loaded onto the NRPS-PKS
hybrid assembly line by an adenylation domain dedicated to
zwitterionic starter units. Then, the megasynthase transforms
DMSP into gonyol, as demonstrated by heterologous pathway
reconstitution in E. coli.
Burkholderia pseudomallei group pathogens cause lethal
infections that are difficult to treat.[1] The best-known
members of this pathogen complex are Burkholderia mallei,
which causes the zoonotic disease glanders, and B. pseudo-
mallei, the causative agent of melioidosis. The low infective
dose needed and the possibility of infections through
inhalation have led to the classification of B. mallei and B.
pseudomallei as biological warfare agents[2] and a threat to
global health.[3] Since infections by these notorious pathogens
are difficult to treat,[4] novel therapeutic approaches such as
anti-virulence strategies are needed. As prerequisite to
disarming pathogens, it is essential to understand their
virulence factors and the biosynthetic pathways involved.[5]
For B. pseudomallei and related pathogens such as the less
virulent model organism B. thailandensis, various macro-
molecular[6] and low-molecular-weight virulence factors[3, 7]
have been identified. Notably, all pathogens of the B.
pseudomallei complex share a gene locus coding for an
unusual modular thiotemplate assembly line with compo-
nents of modular non-ribosomal peptide synthetases (NRPS)
and polyketide synthases (PKS). Gene inactivation experi-
ments unequivocally linked this gene cluster, named bur, to
pathogenicity in nematode[8] and mouse models.[9] However,
the first metabolite associated to this pathway—burkholderic
acid[10] syn. malleilactone[8] (1)—did not exhibit any activity
explaining the phenotypes observed in the infection models.
Recently, we found 1 to be the inactivated form of the true
virulence factor, a highly reactive, cyclopropanol-substituted
congener named bis-malleicyprol (2a, Figure 1A) formed
from the monomer malleicyprol (2b).[11] Nematode and
toxicity assays showed dramatically increased activity of 2a
compared to 1, implicating the cyclopropanol warhead in
virulence.[11] Thus, understanding its biosynthesis would set
the basis for antivirulence strategies. According to stable-
isotope labeling experiments and gene knockouts, the NRPS-
PKS hybrid enzyme BurA assembles the cyclopropanol-
containing fragment of 2b, followed by dimerization to 2a,
which opens to form the inactive propanone-substituted unit
of 1, from a yet unknown methionine (3)-derived C3 building
block and malonyl-CoA (Figure 1B).[10] Yet, structures and
biotransformations of the precursors loaded onto BurA have
remained a riddle. Here we decipher the biogenetic origin of
the rare cyclopropanol warhead of malleicyprol and show that
a set of zwitterionic sulfonium acids initiates biosynthesis that
play key roles in global sulfur cycling.
To elucidate the biogenetic origin of the malleicyprol
warhead we first focused on the NRPS-PKS hybrid enzyme
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BurA and its unknown starter unit. Specifically, we tested for
accumulation of intermediates in a mutant of the malleicyprol
overexpressing strain B. thailandensis Pbur lacking a func-
tional copy of burA (B. thailandensis PburDburA[10]). Candi-
dates for the sulfur-containing pathway intermediates, how-
ever, could not be detected by routine HR-LCMS-based
metabolic profiling. Only a comparative metabolomics anal-
ysis (Pbur vs. PburDburA) searching for highly polar metab-
olites revealed the elusive methionine-derived starter unit.
Compound 4 with m/z 135 accumulates in B. thailandensis
PburDburA cells (Figure 2A). Based on its exact mass (m/z
135.0474; [M+H]+) we deduced the molecular formula
(C5H11O2S) of 4. By comparison with authentic reference
compounds we identified 4 as the zwitterionic compound
dimethylsulfoniopropionate (DMSP; m/z 135.0474; [M+H]+;
Supporting Information, Figure S1). This finding is intriguing
since DMSP plays a pivotal role in the marine organosulfur
cycle, serving as osmolyte for marine algae and as abundant
carbon and sulfur source for bacteria.[12] It is the precursor of
the climate-relevant gas dimethylsulfide that is emitted at
remarkably high amounts of > 107 tons per year into the
atmosphere.[13] Despite its wide distribution, DMSP has thus
far not been implicated as a building block in natural product
biosynthesis.
To confirm DMSP as a precursor of malleicyprols, we
performed stable-isotope labeling experiments by chemically
complementing suitable block mutants. Therefore, we
required insight into the molecular basis of DMSP formation
in B. thailandensis. By analogy to one of the established
bacterial DMSP biosynthesis pathways[12] (see Ref. [14] for
alternative routes to DMSP) methionine would undergo S-
methylation to form S-methylmethionine (5), decarboxyla-
tion, transamination and oxidation (Figure 2 C). In silico
analysis of the bur gene locus revealed candidate genes for
a methyltransferase (BurB), a decarboxylase (BurI), a trans-
aminase (BurD), and a dehydrogenase (BurE) (Figure 2E).
Comparison of the deduced protein sequences to the recently
published bacterial DMSP biosynthetic machinery in Strep-
tomyces mobaraensis[14b] showed BurD and BurE to be almost
identical with their orthologues (96% and 98%), whereas
BurB and BurI are only distantly related to their S.
mobaraensis counterparts (35% and 48%).
To disrupt malleicyprol production, we individually inac-
tivated each of the four putative DMSP biosynthesis genes in
B. thailandensis Pbur by homologous crossover and replace-
ment with a resistance cassette. The DburD and DburE
mutants are still capable of producing the malleicyprol
complex, albeit in reduced amounts (Figure 2D). Possibly,
unspecific housekeeping enzymes take over transamination
of sulfonium amine 6 and oxidation of the instable aldehyde
7.[14b] In contrast, the two main malleicyprol diastereomers are
absent in the DburB (methyltransferase) and DburI (decar-
boxylase) mutants (Figure 2D).
Closer inspection of culture extracts from PburDburI
revealed enrichment of metabolite 5 (m/z 164.0744 in positive
ion mode) that is identical to the unusual charged amino acid
S-methylmethionine 5 (SMM; Figure 1D and Figure S3).
Figure 1. A) Structures of burkholderic acid (1) and bis-malleicyprol
(2a) featuring a cyclopropanol warhead. B) Isotope-labeling studies[10]
suggest acetate and methionine (3) as precursors to malleicyprol (2b),
the monomer[11] of 2a.
Figure 2. Identification of sulfonium intermediates in malleicyprol
biosynthesis. A) Volcano plot analysis comparing pellet extracts of B.
thailandensis variants Pbur and PburDburA. B) Volcano plot analysis
comparing supernatant extracts of B. thailandensis variants Pbur and
PburDburI (Figure S2). C) Proposed DMSP biosynthesis in B. thailan-
densis. D) Production of two bis-malleicyprol (2a, m/z 611.3589)
diastereomers in gene inactivation mutants of B. thailandensis Pbur
monitored by UHPLC-MS (EIC in negative ion mode). E) Genomic
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Since 5 cannot be detected in the mutant lacking burB, its
gene product BurB must act in the biosynthetic pathway
upstream of DMSP. BurBs role in DMSP formation is
remarkable as it belongs to class V of the methyltransferase
superfamilies containing a SET-domain.[15] SET-domain-con-
taining methyltransferases are well studied in eukaryotes and
regulate gene expression through histone lysine methyla-
tion.[15] Yet, little is known about prokaryotic SET-domain
methyltransferases, and natural product modifying methyl-
transferases have exclusively been found in class I (Ross-
mann-like fold) or class III (tetrapyrrole methylase).[16] To
corroborate the function of BurB, we cloned and overex-
pressed burB in Escherichia coli and purified the His6-tagged
protein via Ni-affinity. Incubation of purified BurB with l-
methionine (3) and S-adenosylmethionine (SAM) generated
SMM (Figure 3A), which was detected after derivatization
with 8 to compound 9 (Figure 3A). Thus, BurB represents
a novel C-S bond forming enzyme in secondary metabo-
lism.[17]
Having established the key steps to DMSP in B. thailan-
densis and with suitable null producers at hand, we performed
chemical complementation. Therefore, we synthesized 13C3-
labeled DMSP from 13C3 acrylic acid (10, Figure 3C).
Supplementation of the PburDburI mutant with 13C3-DMSP
not only restored production of the malleicyprols (see Fig-
ure S4) but also enriched 13C in their cyclopropanol residue
(Figure 3B). These results unequivocally confirm DMSP as
a key intermediate in the formation of the malleicyprol
warhead.
Since DMSP accumulates in the DburA mutant, we
reasoned that this unusual zwitterionic substrate would be
activated and loaded onto the bur assembly line. In NRPS,
adenylation (A) domains select, activate and load amino acids
onto the assembly line and are thus regarded as gatekeep-
ers.[18] As bioinformatic substrate predictors[19] failed on
BurA-A we generated a homology model of the A domain.
In this way we noted the absence of the conserved aspartate
(D235 in GrsA-A) present in all a-amino acid activating A
domains.[18] Consequently, BurA-A was expected to select
a non-canonical starter unit lacking the a-amino group
usually bound by this aspartate. According to homology
modeling, BurA-A shares important binding pocket features
with the A-domain ATRR-A activating glycine betaine.[20] In
both ATRR-A and BurA-A, the loop carrying conserved
D235 (GrsA-A) has been replaced with a shorter loop
carrying hydrophobic residues (Figure 4A; Figure S5). In
another position, both binding pockets have an acidic residue
(D606 in BurA-A) well placed to interact with a positively
charged substrate moiety such as the sulfonium group of
DMSP.
To verify whether BurA-A selects and activates DMSP we
cloned and expressed the gene fragment for the A domain
(burA-A) in E. coli BL21(DE3) and purified the His6-tagged
protein via Ni-affinity. We probed the activity of BurA-A with
the MesG/hydroxylamine assay, which monitors pyrophos-
phate released during substrate adenylation in a coupled
photometric assay (Figure 4B).[21] From a panel of carboxylic
acids, BurA-A shows highest activity for DMSP. In stark
contrast, neither a mixture of the proteinogenic amino acids, 5
nor 3-(methylthio)propionic acid (11) are activated (Fig-
ure 4C). Apparently, the positively charged sulfonium group
enables substrate binding. Replacing this group with proton-
ated nitrogen in 12, thus maintaining the positive charge,
reduces activity more than four-fold. In substrate saturation
kinetics with DMSP, we determined a kcat of 2.4 min
1 and
a KM of 0.15 mm (Figure S7). Altogether, these results
indicate that DMSP is the preferred substrate of BurA-A,
making it the first adenylation domain that incorporates the
osmolyte DMSP into a natural product assembly line.
An in silico analysis of the modular architecture of BurA
suggested that DMSP, once loaded onto the thiolation (T)
domain, would be elongated through Claisen condensation
with malonyl-ACP, and the resulting b-keto intermediate
transformed into the corresponding alcohol by the ketore-
ductase (KR) domain (Figure 4E). To identify the down-
stream product of DMSP we heterologously reconstituted the
assembly line. Therefore, we cloned and expressed burA in E.
coli. Only when we employed IPTG for induction and
supplemented DMSP, we detected production of compound
13 with m/z 179.0742 (positive ion mode) in XAD16 extracts
(Figure 4D). The presence of the same species in B.
thailandensis Pbur (Figure 1B) indicates that compound 13
is not an artifact generated in E. coli but actually formed in
the intact bur pathway. By HR-LCMS and MS2 comparison
with an authentic reference we found that 13 is identical to the
sulfonium acid gonyol.[22] The structure of 13 agrees with our
in silico prediction of the biosynthetic steps mediated by
BurA. However, the discovery of this sulfonium intermediate
Figure 3. DMSP is a precursor of the cyclopropanol warhead of
malleicyprol. A) Transformation of methionine (3) to S-methylmethio-
nine (5 ; SMM) by BurB and derivatization with 8 ; HR-LCMS detection
of derivatized SMM; EIC m/z 330.0754 in positive ion mode; top:
SMM derivatized with FDNB, middle: methylation of methionine with
BurB, bottom: heat-inactivated BurB. B) Mass spectra of native bis-
malleicyprol (top) and of 13C-enriched bis-malleicyprol (bottom)
C) Synthesis of 13C-labeled DMSP and subsequent complementation of
B. thailandensis PburDburI leads to incorporation of the C3 unit into 2.
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of the malleicyprol assembly line is surprising, as 13 has been
reported as a dominant zwitterion in the marine dinoflagel-
late Gonyaulax polyedra.[22] Moreover, 13 is widely distrib-
uted as minor osmolyte in several phytoplankton groups.[23]
Previous studies have identified DMSP and acetate as the
precursors of 13 in G. polyedra,[22, 24] but the enzymes involved
in gonyol biosynthesis have remained unknown. We now
report BurA as the first enzyme involved in a gonyol
biosynthetic pathway, and unexpectedly, it is a modular
NRPS-PKS hybrid. We reason that the sulfonium group
represents a leaving group, likely as dimethylsulfide that
enables cyclopropanol formation downstream of BurA. The
enzymes and mechanisms involved in the cyclization are the
subject of ongoing studies.
In summary, we have uncovered crucial steps in the
biosynthetic pathway to the virulence factor malleicyprol
employed by animal and human pathogenic Burkholderia
species. Our findings have broad implications for ecology and
synthetic biology. We describe BurB as a new C-S bond-
forming enzyme in secondary metabolism that mediates
a cryptic methylation to form the sulfonium group of the
DMSP precursor. A role of this zwitterionic sulfonium acid in
bacterial secondary metabolism is new. In contrast, DMSP is
widely distributed in marine life, and metagenomics of known
DMSP methyltransferase genes show that bacteria are
significant producers of DMSP in marine environments.[25]
Our discovery of a new methyltransferase associated with
DMSP biosynthesis and the identification of a PKS-NRPS
hybrid as a gonyol synthetase allows for genomics-based
identification of ecologically relevant producer strains. From
a biosynthetic perspective DMSP is noteworthy as a novel
PKS primer unit,[26] and the sulfonium-accepting adenylation
domain BurA-A is an important addition to the synthetic
biology toolbox that opens up new possibilities for engineer-
ing polyketides and nonribosomal peptides.
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